Schizoaffective disorder sits in the diagnostic space between schizophrenia and primary mood disorders. The DSM-5 criteria require: (1) major mood episodes (manic, depressed, or both) concurrent with psychotic illness criteria, AND (2) at least 2 weeks of psychotic symptoms in the absence of prominent mood symptoms during the lifetime of the illness, AND (3) mood symptoms must be present for a substantial portion (majority) of the total illness duration.
Two subtypes: bipolar type (manic episodes part of the presentation, even if depressive episodes also occur) and depressive type (only depressive mood episodes). The subtype shapes treatment — bipolar type requires mood stabilizer; depressive type may use antidepressant with antipsychotic cover.
How to distinguish from schizophrenia: schizoaffective requires substantial mood episodes (lasting the majority of illness duration); schizophrenia involves minimal mood symptoms or mood symptoms confined to brief portions of the illness.
How to distinguish from bipolar I with psychotic features: in bipolar I, psychotic symptoms occur only during mood episodes (mania or depression). In schizoaffective, psychotic symptoms persist for at least 2 weeks in the absence of prominent mood symptoms — meeting psychotic illness criteria independent of mood.
These distinctions are clinically consequential because treatment differs. Schizoaffective requires both antipsychotic and mood-stabilizing medication indefinitely. Bipolar I with psychotic features may allow antipsychotic taper after acute episode resolution. Schizophrenia requires antipsychotic indefinitely with mood medications optional.
Treatment: antipsychotic plus mood stabilizer (bipolar type) or antipsychotic plus antidepressant (depressive type, with antipsychotic cover preventing mood destabilization). Paliperidone is the only antipsychotic with specific FDA indication for schizoaffective disorder, though many antipsychotics work clinically. Lithium often used in bipolar type. Lamotrigine for depression-predominant patterns. Long-term combination treatment standard.
Coordinated specialty care principles from schizophrenia apply — multidisciplinary treatment, supported employment, family education, attention to metabolic monitoring. Outcomes intermediate between schizophrenia and bipolar I in many measures.
When you encounter a patient with both substantial mood episodes and persistent psychosis beyond mood episodes, schizoaffective is the diagnosis. The distinction from neighboring disorders matters because long-term treatment direction differs.